Lori Maness-Harris, M.D.

Lori_Maness-Harris-Hematology-2017.jpgLori Maness-Harris, M.D.
Associate Professor, Internal Medicine
Division of Oncology & Hematology

Academic Office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 681980-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fax 402-559-6520

Practice locations:
Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)

Nebraska Medicine Village Pointe
111 North 175th Street
Omaha, NE 68118
Ph. 402-596-3100 (map)

Education:
Cornell University, Ithaca, NY, B.S., (1993)
SUNY Health Science Center, Syracuse, NY, M.D., (1997)
University of Connecticut Health Sciences Center, Farmington, CT, Resident, (2000)
University of Colorado Health Sciences Center, Denver, CO, Fellow, (2003)

Hospital Appointments:
Nebraska Medicine

Interests:
Myeloid Malignancies

Biographical Sketch:
Dr. Maness is an Assistant Professor in the Division of Hematology and Oncology in the Department of Internal Medicine at UNMC. She received her clinical training in Internal Medicine at the University of Connecticut Health Sciences Center. Dr. Maness' interest is in the treatment of patients with leukemia, especially those who are elderly. She is also a transplant physician and is involved in investigating the factors that contribute to the occurrence of secondary malignancies among transplant patients. Dr. Maness is a member of the Acute Myelogenous Leukemia Panel of the National Comprehensive Cancer Network.  She has recently been appointed to a position with the American Society of Clinical Oncology.

Select Publications:

O'Donnell MR, Appelbaum FR, Coutre SE, …Maness LJ, et al: Acute myeloid leukemia. J Natl Compr Canc Netw 6(10):962-93, 2008

Greenberg PL, Attar E, Battiwalla M, ...Maness LJ, et al: Myelodysplastic syndrome, J Natl Compr Canc Netw 6(9):902-26, 2008

Ganti AK, Lee SJ, Vose JM, ... Maness LJ, et al. Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning. J Clin Oncol 10;25(35):5643-8, 2007

Maness-Harris LJ. Commentary on Risk-based management of MDS by Steensma DP and Tefferi A. Oncology 2007 Jan; 21(1);57-8, 62

O’Donnell MR, Appelbaum FR, Baer MR…Maness LJ, et al: Acute myeloid leukemia clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network (JNCCN). 2006 Jan; 4(1):16-36

Ganti AK and Maness LJ: Perspectives on the Treatment of Acute Myeloid Leukemia. Oncology Special Edition, Vol. 8, pg. 37-43, 2005

Maness LJ, Loberiza FR, Sanger W, et al. Can elimination of total body irradiation in conditioning regimens for autologous stem cell transplantation in patients with Hodgkin’s and Non-Hodgkin’s lymphoma decrease the risk of secondary AML/MDS? A retrospective case-control study at the University of Nebraska Medical Center. Abstr 682 and oral presentation. ASH 47th Annual Meeting, December 2005

Maness LJ. Perspectives on the Treatment of Acute Myeloid Leukemia. Oncology Special Ed. Vol 7. 19-26, 2004. [Updated annually 2005-2007]

Maness LJ, McSweeney PA. Treatment options for newly diagnosed patients with chronic myeloid leukemia. Curr Hematol Rep. 2004 Jan;3(1):54-61

Additional Publications at PubMed.Gov: https://www.ncbi.nlm.nih.gov/pubmed